Patents by Inventor Ilaria Capua

Ilaria Capua has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200087630
    Abstract: Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in insulin deficiency. The usual cause of this beta cell loss is autoimmune destruction. The inventors provide the first evidence of a causal link between influenza virus infection and the development of type 1 diabetes and/or pancreatitis. This causal link between infection and type 1 diabetes and/or pancreatitis provides various therapeutic, prophylactic and diagnostic opportunities.
    Type: Application
    Filed: July 25, 2019
    Publication date: March 19, 2020
    Applicants: Ospedale San Raffaele S.r.l., Istituto Zooprofilattico Sperimentale delle Venezie
    Inventors: Lorenzo Piemonti, Ilaria Capua
  • Publication number: 20180273912
    Abstract: Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in insulin deficiency. The usual cause of this beta cell loss is autoimmune destruction. The inventors provide the first evidence of a causal link between influenza virus infection and the development of type 1 diabetes and/or pancreatitis. This causal link between infection and type 1 diabetes and/or pancreatitis provides various therapeutic, prophylactic and diagnostic opportunities.
    Type: Application
    Filed: January 5, 2018
    Publication date: September 27, 2018
    Applicants: Ospedale San Raffaele S.r.l., Istituto Zooprofilattico Sperimentale delle Venezie
    Inventors: Lorenzo PIEMONTI, Ilaria CAPUA
  • Publication number: 20150299667
    Abstract: Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in insulin deficiency. The usual cause of this beta cell loss is autoimmune destruction. The inventors provide the first evidence of a causal link between influenza virus infection and the development of type 1 diabetes and/or pancreatitis. This causal link between infection and type 1 diabetes and/or pancreatitis provides various therapeutic, prophylactic and diagnostic opportunities.
    Type: Application
    Filed: October 10, 2013
    Publication date: October 22, 2015
    Applicants: OSPEDALE SAN RAFFAELE S.R.L., ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE
    Inventors: Lorenzo PIEMONTI, Ilaria CAPUA
  • Publication number: 20060121447
    Abstract: Within the prophylaxis strategies for the control of type A avian influenza caused by viral infection with specific epidemic strain H7N1, a vaccination process is envisaged comprising the preparation of a heterologous vaccine that is administered to an animal population, said vaccine featuring the same subtype of viral haemoagglutinin HA7 and a different subtype of neuroaminidase NA3, and thereafter detecting the viralinfection positiveness by contacting an antigen with at least one genomic sequence that codes for a neuroaminidase NA1 protein with the biological fluids collected from the animals By subsequently revealing an antigen-anti-body reaction by means of a test for detecting positiveness (iIFA, ELISA among others), the vaccinated animals can be discriminated from the other ones. The recombinant antigen is represented by the recombinant glycoprotein neuroaminidase NA1, the genomic sequence of which is carried by a baculovirus and expressed in insect cell.
    Type: Application
    Filed: April 12, 2002
    Publication date: June 8, 2006
    Inventors: Ilaria Capua, Stefano Marangon, Giovanni Cattoli